Key Points
- Insider buy: CVS Group director Richard Gray bought 2,000 shares on Jan 5 at an average of £1,276.96 per share, a total transaction of £2,553,920.
- Analyst sentiment and valuation: The stock has a consensus "Moderate Buy" (four Buy, one Hold) with a target of GBX 1,724, while trading around GBX 1,288 (12‑month range GBX 800–1,648), market cap ~£914.97m and a P/E of 17.5.
CVS Group plc (LON:CVSG - Get Free Report) insider Richard Gray bought 2,000 shares of the stock in a transaction that occurred on Monday, January 5th. The shares were purchased at an average cost of £1,276.96 per share, for a total transaction of £2,553,920.
CVS Group Price Performance
Shares of LON CVSG opened at GBX 1,288 on Wednesday. CVS Group plc has a twelve month low of GBX 800 and a twelve month high of GBX 1,648. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52. The company has a market capitalization of £914.97 million, a price-to-earnings ratio of 17.50, a PEG ratio of 1.77 and a beta of 1.02. The firm has a 50-day moving average of GBX 1,224.93 and a two-hundred day moving average of GBX 1,247.42.
CVS Group (LON:CVSG - Get Free Report) last announced its quarterly earnings data on Tuesday, October 7th. The company reported GBX 80.10 earnings per share (EPS) for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. As a group, analysts expect that CVS Group plc will post 93.9393939 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research analysts have issued reports on CVSG shares. Peel Hunt restated a "buy" rating and issued a GBX 1,600 price target on shares of CVS Group in a research report on Tuesday, November 18th. Royal Bank Of Canada increased their price objective on CVS Group from GBX 1,500 to GBX 1,900 and gave the company an "outperform" rating in a research report on Tuesday, October 21st. Deutsche Bank Aktiengesellschaft lifted their target price on CVS Group from GBX 1,500 to GBX 1,700 and gave the stock a "buy" rating in a report on Tuesday, October 21st. Jefferies Financial Group boosted their target price on CVS Group from GBX 1,250 to GBX 1,420 and gave the stock a "hold" rating in a research report on Wednesday, October 22nd. Finally, Berenberg Bank reaffirmed a "buy" rating and set a GBX 2,000 target price on shares of CVS Group in a report on Tuesday, November 18th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of GBX 1,724.
Check Out Our Latest Research Report on CVS Group
About CVS Group
(
Get Free Report)
CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
